AI assistant
Sending…
Co-Diagnostics, Inc. — Director's Dealing 2017
Aug 16, 2017
35011_dirs_2017-08-16_f84c3a82-25a3-4ad6-807d-277ecd35bb9a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2017-07-11-06:00
Reporting Person: Egan Dwight H (N/A)
More from Co-Diagnostics, Inc.
Capital/Financing Update
2026
May 28
Capital/Financing Update
2026
May 21
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
Feb 11
Regulatory Filings
2026
Jan 21
Delisting Announcement
2026
Jan 13
Share Issue/Capital Change
2025
Dec 30
Capital/Financing Update
2025
Dec 19
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 5